Update on Cancer Drug Nilotinib for Parkinson's Disease

This is an archived file of a live webcast that took place on August 2, 2016.

In this webinar, clinicians, researchers and a patient share the current state of science and safety around the cancer drug nilotinib for the treatment of Parkinson's disease. Our panel also discuss plans for future testing.

Title: Update on Cancer Drug Nilotinib for Parkinson's Disease

Duration: 1 hour

Continuing Medical Education Information for Health Care Professionals

MJFF is not offering CME credit for this webinar. Visit www.michaeljfox.org/webinars for our library of CME-accredited Third Thursdays webinars.

Register

Already Registered?

*Required Fields.

You must have Javascript and Cookies enabled to access this webcast. Click here for Help.